These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 26987443
1. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner. Zhong ZF, Tan W, Qiang WW, Scofield VL, Tian K, Wang CM, Qiang WA, Wang YT. Mol Biosyst; 2016 Apr 26; 12(5):1626-37. PubMed ID: 26987443 [Abstract] [Full Text] [Related]
2. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo. Zhong Z, Dang Y, Yuan X, Guo W, Li Y, Tan W, Cui J, Lu J, Zhang Q, Chen X, Wang Y. Cell Physiol Biochem; 2012 Apr 26; 30(3):778-90. PubMed ID: 22854281 [Abstract] [Full Text] [Related]
3. Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro. Zhong ZF, Tan W, Tian K, Yu H, Qiang WA, Wang YT. Oncol Rep; 2017 Apr 26; 37(4):2016-2024. PubMed ID: 28184941 [Abstract] [Full Text] [Related]
4. Furanodiene enhances the anti-cancer effects of doxorubicin on ERα-negative breast cancer cells in vitro. Zhong ZF, Qiang WA, Wang CM, Tan W, Wang YT. Eur J Pharmacol; 2016 Mar 05; 774():10-9. PubMed ID: 26607462 [Abstract] [Full Text] [Related]
5. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner. Zhong ZF, Li YB, Wang SP, Tan W, Chen XP, Chen MW, Wang YT. J Cell Biochem; 2012 Aug 05; 113(8):2643-51. PubMed ID: 22422660 [Abstract] [Full Text] [Related]
6. Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells. Xiao Y, Yang FQ, Li SP, Gao JL, Hu G, Lao SC, Conceição EL, Fung KP, Wangl YT, Lee SM. Cancer Biol Ther; 2007 Jul 05; 6(7):1044-50. PubMed ID: 17611410 [Abstract] [Full Text] [Related]
7. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro. Zhong Z, Tan W, Chen X, Wang Y. Eur J Pharmacol; 2014 Aug 15; 737():1-10. PubMed ID: 24824922 [Abstract] [Full Text] [Related]
8. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT. J Ethnopharmacol; 2012 Jun 01; 141(2):721-7. PubMed ID: 21911050 [Abstract] [Full Text] [Related]
9. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Hien TT, Kim HG, Han EH, Kang KW, Jeong HG. Mol Nutr Food Res; 2010 Jul 01; 54(7):918-28. PubMed ID: 20077420 [Abstract] [Full Text] [Related]
10. Sensitization and synergistic anti-cancer effects of Furanodiene identified in zebrafish models. Zhu XY, Guo DW, Lao QC, Xu YQ, Meng ZK, Xia B, Yang H, Li CQ, Li P. Sci Rep; 2019 Mar 14; 9(1):4541. PubMed ID: 30872660 [Abstract] [Full Text] [Related]
11. Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Ji C, Yang B, Yang YL, He SH, Miao DS, He L, Bi ZG. Oncogene; 2010 Dec 16; 29(50):6557-68. PubMed ID: 20802518 [Abstract] [Full Text] [Related]
12. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Zheng QY, Jin FS, Yao C, Zhang T, Zhang GH, Ai X. Biochem Biophys Res Commun; 2012 Mar 23; 419(4):741-7. PubMed ID: 22387548 [Abstract] [Full Text] [Related]
13. Potential anti-cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin. Sun XY, Zheng YP, Lin DH, Zhang H, Zhao F, Yuan CS. Am J Chin Med; 2009 Mar 23; 37(3):589-96. PubMed ID: 19606517 [Abstract] [Full Text] [Related]
14. Vielanin K enhances doxorubicin-induced apoptosis via activation of IRE1α- TRAF2 - JNK pathway and increases mitochondrial Ca2 + influx in MCF-7 and MCF-7/MDR cells. Zhang LN, Xia YZ, Zhang C, Zhang H, Luo JG, Yang L, Kong LY. Phytomedicine; 2020 Nov 23; 78():153329. PubMed ID: 32896708 [Abstract] [Full Text] [Related]
15. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK, Wang ZL, Pan ST, Ding HQ, Au GH, He ZX, Zhou ZW, Xiao G, Yang YX, Zhang X, Yang T, Chen XW, Qiu JX, Zhou SF. Drug Des Devel Ther; 2015 Nov 23; 9():1555-84. PubMed ID: 25792811 [Abstract] [Full Text] [Related]
16. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing. Wu Y, Sarkissyan M, Mcghee E, Lee S, Vadgama JV. Breast Cancer Res Treat; 2015 Jun 23; 151(3):529-39. PubMed ID: 25975952 [Abstract] [Full Text] [Related]
17. Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction. Luo F, Zhao J, Liu S, Xue Y, Tang D, Yang J, Mei Y, Li G, Xie Y. Biochem Pharmacol; 2022 Nov 23; 205():115278. PubMed ID: 36191625 [Abstract] [Full Text] [Related]
18. Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells. Chaisit S, Jianmongkol S. Biol Pharm Bull; 2021 Nov 23; 44(9):1239-1246. PubMed ID: 34471052 [Abstract] [Full Text] [Related]
19. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells. Dartier J, Lemaitre E, Chourpa I, Goupille C, Servais S, Chevalier S, Mahéo K, Dumas JF. Biochim Biophys Acta Gen Subj; 2017 May 23; 1861(5 Pt A):1075-1084. PubMed ID: 28214549 [Abstract] [Full Text] [Related]
20. Induction of Apoptosis by Citrus unshiu Peel in Human Breast Cancer MCF-7 Cells: Involvement of ROS-Dependent Activation of AMPK. Kim MY, Bo HH, Choi EO, Kwon DH, Kim HJ, Ahn KI, Ji SY, Jeong JW, Park SH, Hong SH, Kim GY, Park C, Kim HS, Moon SK, Yun SJ, Kim WJ, Choi YH. Biol Pharm Bull; 2018 May 23; 41(5):713-721. PubMed ID: 29709909 [Abstract] [Full Text] [Related] Page: [Next] [New Search]